华大智造DNBSEQ-T1+测序仪获CE认证-动脉网

MGI Tech Receives CE Mark for DNBSEQ-T1+ Sequencer

CISION 等信源发布 2025-06-20 14:54



可切换为仅中文







SHENZHEN, China

中国深圳

，

June 20, 2025

2025年6月20日

/PRNewswire/ -- MGI Tech Co., Ltd. ('MGI'), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced that its latest mid-throughput sequencer

/PRNewswire/ -- 专注于开发生命科学领域核心工具和技术的公司MGI Tech Co., Ltd.（“MGI”）今天宣布，其最新的中通量测序仪

DNBSEQ-T1+ ('T1+')

DNBSEQ-T1+（“T1+”）

has received the CE mark under the EU certification framework. This certification paves the way for the T1+ to enter the EU market for both research and clinical applications, marking a significant milestone in its global expansion.

已获得欧盟认证框架下的CE标志。该认证为T1+进入欧盟市场进行研究和临床应用铺平了道路，标志着其全球扩展的一个重要里程碑。

Unveiled at AGBT 2025 this year, the T1+ is a flagship benchtop genetic sequencer designed to deliver a mid-throughput sequencing capability. With the capability to perform a paired-end 150 sequencing workflow in just 24 hours with Q40 accuracy, the T1+ stands out as one of the fastest mid-throughput sequencers on the globe with industrial leading sequencing speed..

在今年的AGBT 2025上亮相的T1+是一款旗舰级台式基因测序仪，旨在提供中通量的测序能力。T1+能够在24小时内以Q40的准确度完成配对末端150测序流程，凭借其工业领先的测序速度，成为全球最快的中通量测序仪之一。

Featuring three flow cell formats and two to four addressable lanes per flow cell, the T1+ is also distinguished by its versatility. The T1+ supports a data output ranging from 25 to 1,200 Gb. This adaptability allows researchers to conduct independent experiments on a single platform, significantly enhancing laboratory efficiency and flexibility. .

T1+ 具有三种流动槽格式，每个流动槽有两条到四条可寻址通道，其多功能性也十分突出。T1+ 支持 25 至 1,200 Gb 的数据输出范围。这种适应性使研究人员能够在单一平台上进行独立实验，显著提升了实验室的效率和灵活性。

Beyond its advanced capabilities, the T1+ is equipped with integrated auto-DNB making and loading systems as well as a built-in bioinformatics module, which enhances the user experience with eased workflow. These innovations allow the T1+ to support a wide array of applications in genomics, giving users a seamless sequencing journey that boosts productivity across various research endeavors..

除了其先进的功能外，T1+还配备了集成的自动DNB制备和加载系统以及内置的生物信息学模块，这些都通过简化的工作流程提升了用户体验。这些创新使T1+能够支持基因组学中的广泛应用，为用户提供无缝的测序体验，提高各种研究工作的效率。

'The CE marking is a strong affirmation that T1+ is in full compliance with the standards and regulations stipulated by the EU for research and clinical applications,' stated

“CE标志有力地证明了T1+完全符合欧盟为研究和临床应用所规定的所有标准和法规，”声明指出。

Duncan Yu

邓肯·余

, President of MGI. 'We are confident that the availability of T1+ is promising in driving advancement and breakthroughs of genomics and empowering EU researchers and clinicians to progress in areas like precision medicine and oncology with its precise, efficient, and versatile sequencing capability.'.

MGI总裁表示：“我们相信，T1+的推出有望推动基因组学的进步和突破，并通过其精确、高效和多功能的测序能力，助力欧盟研究人员和临床医生在精准医学和肿瘤学等领域取得进展。”

The T1+ made its debut in the European market ESHG exhibition this year and attracted widespread attention from attendees, who showed great interest in the hands-on experience and practical applications.

T1+ 在今年的欧洲市场 ESHG 展会上首次亮相，吸引了与会者的广泛关注，他们对亲身体验和实际应用表现出极大的兴趣。

About MGI:

关于MGI：

MGI Tech Co., Ltd. (or its subsidiaries, together referred to as MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology.

MGI Tech Co., Ltd.（或其子公司，统称为MGI）致力于构建推动生命科学创新的核心工具和技术。我们专注于生命科学和生物技术领域的仪器、试剂及相关产品的研发、制造和销售。

We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various other industries..

我们为精准医学、农业、医疗保健和各种其他行业提供实时、多组学和全方位的数字设备和系统。

Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and establishing research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels.

2016年成立的MGI，现已成长为生命科学领域的领导者，为六大洲的客户提供服务，并在全球范围内建立了研发、生产、培训和售后服务中心。MGI是少数能够独立研发并量产从Gb到Tb级不同通量临床级基因测序仪的公司之一。

With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future..

凭借无与伦比的专业知识、尖端产品和对全球影响力的承诺，MGI继续塑造生命科学未来的轨迹。

For more information, please

更多信息，请参阅

visit

访问

https://en.mgi-tech.com/

，

领英

，

and

和

YouTube